China's Antubio (603658.SH) announced that it signed an agreement with Mobidiag Oy of Finland on December 15 to buy a 10.12-percent stake in the latter for about 9.99 million euros.
Meanwhile, the two companies also decided to invest 12.3 million euros to set up a joint venture (JV). The Shanghai-listed company will invest 8 million euros in the JV and hold a 65-percent stake and Mobidiag Oy will contribute 4.3 million euros to the JV and take a 35-percent stake.
Antubio is a company engaged mainly in developing, producing and selling the in vitro diagnostic reagents and instruments.
Mobidiag is a Finnish-based high-tech company that specializes in the design, development, production and sales of molecular diagnostic products.
Meanwhile, the two companies also decided to invest 12.3 million euros to set up a joint venture (JV). The Shanghai-listed company will invest 8 million euros in the JV and hold a 65-percent stake and Mobidiag Oy will contribute 4.3 million euros to the JV and take a 35-percent stake.
Antubio is a company engaged mainly in developing, producing and selling the in vitro diagnostic reagents and instruments.
Mobidiag is a Finnish-based high-tech company that specializes in the design, development, production and sales of molecular diagnostic products.
Latest comments